BioRem Inc.
BIRMF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $37,419 | $25,165 | $28,863 | $24,478 |
| % Growth | 48.7% | -12.8% | 17.9% | – |
| Cost of Goods Sold | $27,363 | $18,143 | $20,101 | $18,242 |
| Gross Profit | $10,056 | $7,022 | $8,762 | $6,236 |
| % Margin | 26.9% | 27.9% | 30.4% | 25.5% |
| R&D Expenses | $44 | $30 | $97 | $14 |
| G&A Expenses | $2,124 | $1,627 | $3,203 | $1,816 |
| SG&A Expenses | $5,618 | $3,905 | $5,786 | $3,913 |
| Sales & Mktg Exp. | $3,494 | $2,279 | $2,583 | $2,098 |
| Other Operating Expenses | $50 | $24 | $0 | $0 |
| Operating Expenses | $5,712 | $3,959 | $5,883 | $3,903 |
| Operating Income | $4,344 | $3,063 | $2,641 | $2,070 |
| % Margin | 11.6% | 12.2% | 9.1% | 8.5% |
| Other Income/Exp. Net | -$195 | -$273 | -$257 | -$36 |
| Pre-Tax Income | $4,148 | $2,789 | $2,383 | $2,034 |
| Tax Expense | $1,105 | $610 | $770 | $737 |
| Net Income | $3,044 | $2,179 | $1,613 | $1,297 |
| % Margin | 8.1% | 8.7% | 5.6% | 5.3% |
| EPS | 0.19 | 0.14 | 0.1 | 0.036 |
| % Growth | 35.7% | 40% | 177% | – |
| EPS Diluted | 0.16 | 0.13 | 0.092 | 0.035 |
| Weighted Avg Shares Out | 15,765 | 15,672 | 15,485 | 35,922 |
| Weighted Avg Shares Out Dil | 18,714 | 17,107 | 17,555 | 37,411 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $195 | $273 | $257 | $36 |
| Depreciation & Amortization | $473 | $383 | $351 | $344 |
| EBITDA | $4,817 | $3,445 | $2,991 | $2,677 |
| % Margin | 12.9% | 13.7% | 10.4% | 10.9% |